Abstract:
Objective To investigate the effect of different radiotherapy doses on the prognosis of subgroups with different tumor local factors in patients with esophageal squamous cell carcinoma who received radical radio(chemo)therapy.Methods A retrospective analysis of 256 patients with non-metastatic esophageal squamous cell carcinoma was performed.First, the optimal cut-off value of tumor local factor indicators to predict the prognosis of this group of patients was determined.The relationship between short-term curative effect and relevant indicators of local tumor factors was analyzed.A multivariate analysis was performed, and finally a subgroup analysis was performed to further identify the subgroups that benefited from different radiation doses.Results The X-ray length of tumor esophageal lesions, the maximum thickness of esophageal lesions and the size of GTV could predict the prognosis of patients.he shorter the esophageal lesion, the smaller the wall thickness and GTV, the better the short-term curative effect of the patients (X
2=9.066, 10.310, 15.661, P=0.011, 0.006, 0.000).The results of multivariate analysis showed that esophageal GTV, radiotherapy dose and short-term efficacy were independent indicators affecting the prognosis of patients with OS (P=0.000, 0.038, 0.000), and the latter two indicators were also independent indicators affecting the prognosis of patients with PFS(P=0.033, 0.000).The results of subgroup analysis showed that when the radiation dose was higher(≥60Gy), the maximum thickness of the vessel wall was less than or equal to 3.7cm, the GTV of esophageal lesions was less than or equal to 37.34cm
3, and the patients who did not receive concurrent chemotherapy had better OS (X2=5.040, 4.588, 5.400, P=0.025, 0.032, 0.020) and PFS (X2=6.089, 4.353, 6.459, P=0.014, 0.037, 0.011).Conclusion Local tumor factors are important prognostic factors for patients with esophageal squamous cell carcinoma receiving radical radio(chemo)therapy;patients with smaller lesion esophageal wall thickness and tumor volume may be better able to benefit from higher dose (≥60Gy) irradiation.Relevant final conclusions require further prospective, randomized controlled studies with large numbers of cases.